Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 6 studies | 28% ± 6% | |
| endothelial cell | 5 studies | 23% ± 8% | |
| GABAergic neuron | 5 studies | 37% ± 17% | |
| epithelial cell | 4 studies | 25% ± 5% | |
| glutamatergic neuron | 4 studies | 52% ± 18% | |
| astrocyte | 4 studies | 23% ± 9% | |
| microglial cell | 3 studies | 17% ± 0% | |
| oligodendrocyte precursor cell | 3 studies | 26% ± 5% | |
| interneuron | 3 studies | 43% ± 20% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 37% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 3367.85 | 459 / 459 | 100% | 23.18 | 1118 / 1118 |
| esophagus | 100% | 2871.57 | 1445 / 1445 | 100% | 19.46 | 183 / 183 |
| prostate | 100% | 3830.64 | 245 / 245 | 100% | 23.52 | 502 / 502 |
| uterus | 100% | 3940.96 | 170 / 170 | 100% | 22.06 | 459 / 459 |
| lung | 100% | 2803.34 | 577 / 578 | 100% | 16.86 | 1155 / 1155 |
| bladder | 100% | 2932.10 | 21 / 21 | 100% | 16.99 | 503 / 504 |
| ovary | 100% | 3955.68 | 180 / 180 | 100% | 12.72 | 429 / 430 |
| thymus | 100% | 3579.57 | 653 / 653 | 100% | 18.02 | 603 / 605 |
| pancreas | 100% | 2437.48 | 328 / 328 | 99% | 17.26 | 177 / 178 |
| adrenal gland | 100% | 3079.77 | 258 / 258 | 99% | 13.94 | 228 / 230 |
| brain | 99% | 2685.30 | 2615 / 2642 | 100% | 19.08 | 705 / 705 |
| stomach | 100% | 2457.33 | 359 / 359 | 98% | 13.27 | 281 / 286 |
| kidney | 100% | 2341.94 | 89 / 89 | 98% | 13.76 | 885 / 901 |
| intestine | 100% | 3401.41 | 966 / 966 | 98% | 14.01 | 517 / 527 |
| skin | 100% | 3661.27 | 1809 / 1809 | 94% | 15.28 | 442 / 472 |
| liver | 99% | 1337.89 | 224 / 226 | 91% | 8.27 | 371 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.00 | 29 / 29 |
| spleen | 100% | 3438.93 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 16.35 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.79 | 1 / 1 |
| adipose | 100% | 2918.20 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2430.89 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1680.45 | 799 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 1334.44 | 842 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 66% | 8.52 | 53 / 80 |
| peripheral blood | 40% | 1102.76 | 375 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000395 | Biological process | mRNA 5'-splice site recognition |
| GO_0000243 | Cellular component | commitment complex |
| GO_0071004 | Cellular component | U2-type prespliceosome |
| GO_0005685 | Cellular component | U1 snRNP |
| GO_0005515 | Molecular function | protein binding |
| GO_0030627 | Molecular function | pre-mRNA 5'-splice site binding |
| Gene name | PRPF39 |
| Protein name | PRPF39 protein Pre-mRNA processing factor 39 Pre-mRNA-processing factor 39 (PRP39 homolog) |
| Synonyms | |
| Description | FUNCTION: Involved in pre-mRNA splicing. . |
| Accessions | ENST00000554439.5 ENST00000553605.1 ENST00000554429.5 ENST00000554081.5 Q05CV8 F8WB90 G3V5M7 H0YJY9 ENST00000557477.1 ENST00000424478.5 Q86UA1 ENST00000355765.11 [Q86UA1-1] H0YJR1 |